Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 86001-86050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06318559
Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention
NA
Recruiting
120 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
2 locations
NCT05408715
A Natural History Study in Children With a Type II Collagen Disorder With Short Stature
N/A
Recruiting
60 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2026
4 conditions
1 sponsor
2 locations
NCT05492721
Comparing Tissue Adhesives in Port Site Closure
PHASE3
Recruiting
184 participants
Started: Jun 29, 2022 · Completed: Oct 29, 2025
1 condition
1 sponsor
1 location
NCT04780646
Effects of Urban Nature on Stress and Quality of Life
NA
Recruiting
93 participants
Started: Jun 29, 2022 · Completed: Dec 15, 2024
1 condition
1 sponsor
1 location
NCT05239858
International Wilson's Disease Patient Registry (iWilson Registry)
N/A
Recruiting
500 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
16 locations
NCT05373940
Cardioverter DefIbriIlator PlacEMent for priMary Prevention of Sudden cArdiac Death in Patients Older Than 70 Years
NA
Recruiting
730 participants
Started: Jun 29, 2022 · Completed: May 31, 2030
3 conditions
2 sponsors
19 locations
NCT05530759
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
N/A
Recruiting
50 participants
Started: Jun 29, 2022 · Completed: Apr 7, 2028
2 conditions
1 sponsor
1 location
NCT05382364
Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)
PHASE1
Active, not recruiting
25 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
5 locations
NCT05405673
Diagnostic Accuracy of a Panel of Bacterial Gene Markers (M3) for Colorectal Advanced Neoplasia
N/A
Recruiting
2,500 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2025
3 conditions
11 sponsors
1 location
NCT04859764
Effect of Reparel Knee Sleeve with Knee Injection
NA
Recruiting
74 participants
Started: Jun 29, 2022 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT05516212
Caffeine Kinetics and CrossFit®-Specific Performance
PHASE2/PHASE3
Recruiting
25 participants
Started: Jun 29, 2022 · Completed: Jul 30, 2024
4 conditions
3 sponsors
1 location
NCT04678869
CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)
NA
Recruiting
1,052 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2031
1 condition
2 sponsors
14 locations
NCT06714149
Impacts of Nitrogen Deposition in the Natural Environment on Pollen Allergy in Belgium
NA
Recruiting
200 participants
Started: Jun 29, 2022 · Completed: Apr 30, 2025
1 condition
5 sponsors
1 location
NCT05323292
Vitamin A Status in Patients With Vocal Fold Leukoplakia
N/A
Enrolling by invitation
90 participants
Started: Jun 29, 2022 · Completed: Dec 31, 2026
4 conditions
2 sponsors
1 location
NCT05283044
Implementing Precision Medicine in cOmmunity HospiTALs
NA
Recruiting
10,000 participants
Started: Jun 29, 2022 · Completed: Apr 15, 2030
1 condition
1 sponsor
21 locations
NCT05389371
OA Optimization Program Pilot Trial
PHASE1/PHASE2
Active, not recruiting
70 participants
Started: Jun 28, 2022 · Completed: Sep 30, 2025
4 conditions
2 sponsors
1 location
NCT05399654
A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors
PHASE1/PHASE2
Active, not recruiting
72 participants
Started: Jun 28, 2022 · Completed: May 19, 2026
1 condition
1 sponsor
12 locations
NCT05173818
Hyperbaric Oxygen Effects on Persistent Post-concussive Symptoms
PHASE2
Active, not recruiting
40 participants
Started: Jun 28, 2022 · Completed: Sep 30, 2025
2 conditions
5 sponsors
1 location
NCT06317428
NT-proBNP Levels During Triple Therapy With Formoterol/Glycopyrrolate/Budesonide in Patients With COPD.
N/A
Recruiting
29 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
2 locations
NCT05119556
Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease
NA
Recruiting
768 participants
Started: Jun 28, 2022 · Completed: Jul 31, 2028
1 condition
2 sponsors
15 locations
NCT05139277
Evaluation of the CONVIVO System
NA
Recruiting
30 participants
Started: Jun 28, 2022 · Completed: Jun 30, 2025
6 conditions
2 sponsors
1 location
NCT05785208
Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status.
PHASE4
Recruiting
122 participants
Started: Jun 28, 2022 · Completed: Oct 31, 2025
1 condition
1 sponsor
11 locations
NCT06322173
Molecular Diagnostics of Bacterial Infections and Antibiotic Resistance in Blood Samples and Rectal Swabs Using Advanced NGS Sequencing Methods
NA
Recruiting
100 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04901169
Angiotensin II in Liver Transplantation
PHASE2/PHASE3
Recruiting
50 participants
Started: Jun 28, 2022 · Completed: Sep 1, 2026
2 conditions
2 sponsors
1 location
NCT05113368
Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
PHASE2
Recruiting
31 participants
Started: Jun 28, 2022 · Completed: Feb 28, 2027
2 conditions
2 sponsors
1 location
NCT05405660
A Study of CDX-0159 in Patients With Chronic Inducible Urticaria
PHASE2
Active, not recruiting
196 participants
Started: Jun 28, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
76 locations
NCT05388227
Pole Walking Intervention in Retirement Communities
NA
Recruiting
50 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT05695352
Oral Levonorgestrel Plus Meloxicam, IG-002 Delays Ovulation in Normal Menstruating Women by Seven Days
PHASE2
Recruiting
21 participants
Started: Jun 28, 2022 · Completed: Nov 30, 2025
1 condition
2 sponsors
1 location
NCT06308692
Molecular Diagnostics of Bacterial Infections and Antibiotic Resistance in Blood Samples and Rectal Swabs Using Real Time PCR-ARES PCR Methods
NA
Recruiting
100 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05878691
A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.
PHASE1
Active, not recruiting
320 participants
Started: Jun 28, 2022 · Completed: Jul 30, 2027
2 conditions
1 sponsor
18 locations
NCT05335252
Dronabinol After Arthroscopic Surgery
PHASE3
Recruiting
30 participants
Started: Jun 28, 2022 · Completed: Jun 30, 2027
8 conditions
1 sponsor
1 location
NCT05461339
TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration
PHASE3
Active, not recruiting
488 participants
Started: Jun 28, 2022 · Completed: Feb 28, 2025
1 condition
2 sponsors
56 locations
NCT05281328
A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD
PHASE2/PHASE3
Active, not recruiting
71 participants
Started: Jun 28, 2022 · Completed: Aug 31, 2027
1 condition
1 sponsor
11 locations
NCT04539392
Assessment of the Sexuality of the Infertile Couple
N/A
Recruiting
80 participants
Started: Jun 28, 2022 · Completed: Sep 30, 2025
1 condition
1 sponsor
1 location
NCT05058651
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
PHASE2/PHASE3
Recruiting
189 participants
Started: Jun 28, 2022 · Completed: Oct 1, 2028
4 conditions
1 sponsor
228 locations
NCT06284161
QCT in ALS Diagnosis, Mechanistic Understanding and Follow-up
NA
Recruiting
30 participants
Started: Jun 28, 2022 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT05025813
Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma
PHASE2
Recruiting
27 participants
Started: Jun 28, 2022 · Completed: Jun 1, 2027
2 conditions
2 sponsors
3 locations
NCT05413759
RhEumatoid Arthritis MEDIcation Adherence
NA
Recruiting
200 participants
Started: Jun 28, 2022 · Completed: Dec 28, 2027
1 condition
1 sponsor
2 locations
NCT05286294
Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders
PHASE2
Active, not recruiting
20 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2034
6 conditions
1 sponsor
1 location
NCT05393258
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
NA
Active, not recruiting
13 participants
Started: Jun 28, 2022 · Completed: May 27, 2026
3 conditions
1 sponsor
1 location
NCT05312281
Study Comparing Postoperative Treatment After Surgical Decompression for Lumbar Spinal Stenosis.
NA
Recruiting
100 participants
Started: Jun 28, 2022 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT05903469
Implicit and Explicit Assessment of Suicide Risk
NA
Recruiting
108 participants
Started: Jun 28, 2022 · Completed: Jan 31, 2026
4 conditions
2 sponsors
1 location
NCT05312255
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
NA
Recruiting
175 participants
Started: Jun 28, 2022 · Completed: Jun 28, 2027
4 conditions
1 sponsor
1 location
NCT05754814
SUper-Resolution Ultrasound Imaging of Erythrocytes (SURE) in Normal and Malignant Lymph Nodes
N/A
Recruiting
100 participants
Started: Jun 28, 2022 · Completed: Apr 30, 2026
3 conditions
3 sponsors
2 locations
NCT05318105
Ultrafiltration Versus IV Diuretics in Worsening Heart Failure
NA
Recruiting
372 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
17 locations
NCT05319431
A Phase II Study of AK104 Plus Lenvatinib and TACE in HCC
PHASE2
Active, not recruiting
60 participants
Started: Jun 28, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
5 locations
NCT05441488
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
PHASE3
Active, not recruiting
800 participants
Started: Jun 28, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
37 locations
NCT04781491
Effects of Nature and Forest Therapy in Patients With Metabolic Syndrome and Cardiovascular Risk Factors
NA
Recruiting
100 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04763343
Ketamine Treatment of Youth Suicide Attempters
PHASE3
Recruiting
60 participants
Started: Jun 27, 2022 · Completed: Aug 31, 2026
1 condition
4 sponsors
2 locations
NCT07016997
A Phase I, First in Human Study of CBA-1535, T Cell Engager(5T4/CD3/5T4) in Patients With Advanced Solid Tumors.
PHASE1
Recruiting
70 participants
Started: Jun 27, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
2 locations
Previous
1
More pages
1718
1719
1720
1721
1722
1723
1724
More pages
2369
Next